T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0028
+0.0003 (12.00%)
Jan 28, 2026, 1:17 PM EST
T2 Biosystems Market Cap
T2 Biosystems has a market cap or net worth of $78.53 thousand as of January 28, 2026. Its market cap has decreased by -98.92% in one year.
Market Cap
78.53K
Enterprise Value
16.94M
Revenue
7.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 7, 2014, T2 Biosystems's market cap has decreased from 274.87M to 78.53K, a decrease of -99.97%. That is a compound annual growth rate of -50.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 70.11K | -50.00% |
| Dec 31, 2025 | 140.23K | -98.41% |
| Dec 31, 2024 | 8.84M | -65.23% |
| Dec 29, 2023 | 25.42M | 144.54% |
| Dec 30, 2022 | 10.39M | -87.87% |
| Dec 31, 2021 | 85.67M | -53.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centogene | 3.13M |
| InVitro International | 2.67M |
| ProPhase Labs | 1.00M |
| NovelStem International | 862.62K |
| IDenta | 817.21K |
| Medical Imaging | 31.91K |
| CardioGenics Holdings | 14.29K |
| RushNet | 8.77K |